engineered IL18 heterodimeric Fc-fusion

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug Nameengineered IL18 heterodimeric Fc-fusion
Drug Alias Nameengineered IL-18 heterodimeric Fc-fusionengineered IL18 heterodimeric Fc-fusion
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionInterleukin 18 inhibitors
TargetsInterleukin 18
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXencor Inc
China Registration ClassN/A

Develop Information

Active CompaniesXencor Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A